Sen. Grassley questions research done by orthopedic surgeon
Wall Street Journal Health Blog, September 23, 2009
Sen. Chuck Grassley is continuing to raise questions about research done by orthopedic surgeon David W. Polly Jr., a Medtronic Inc. consultant and chief of the spine service at the University of Minnesota. Grassley wrote to the university's president raising issues of possible conflict of interest on Polly's part in research on a Medtronic bone-growth product called Infuse. Grassley has been raising questions about doctors who also serve as consultants to drug companies and medical-device makers, and raised the issue of whether Polly might not have alternatively chosen to do his research on another bone-growth product made by a competitor.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- How Chargemaster Data May Affect Hospital Revenue
- Insurer's App Aims to Lower Healthcare Costs, Securely
- ED Physicians Key to Half of Hospital Admissions
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Building a Better Healthcare Board
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Don't Let Nurses Sink Your Bottom Line
- Hospital Pricing Irks Nurses; More Jobs, Less Pay
